The global demand for Myopia and Presbyopia Treatment Market is presumed to reach the market size of nearly USD 77.78 BN by 2030 from USD 28.92 BN in 2022 with a CAGR of 11.62% under the study period 2023-2030.
Myopia and presbyopia are two common vision conditions that require treatment. Myopia, also known as nearsightedness, is a condition in which objects that far away appear blurry. Presbyopia, on the other hand, is a condition in which the eye gradually loses its ability to focus on nearby objects as a person ages.
The prevalence of myopia and presbyopia is increasing worldwide due to changing lifestyle habits and an ageing population. This is driving the demand for effective treatment options. The development of new surgical techniques, contact lenses, and pharmaceuticals is driving the growth of the market. There is a growing awareness among patients and healthcare providers about the available treatment options for myopia and presbyopia. This is leading to greater demand for treatment options and driving the growth of the market. Minimally invasive procedures are in demand for the treatment of myopia and presbyopia. This is due to the benefits of such procedures, including faster recovery times and reduced risk of complications. The increasing healthcare expenditure, particularly in emerging economies, is driving the growth of myopia and presbyopia treatment market. As healthcare systems continue to expand and improve in these countries, more patients are gaining access to treatment options.
The research report covers Porter’s Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry’s structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of myopia and presbyopia treatment. The growth and trends of myopia and presbyopia treatment industry provide a holistic approach to this study.
This section of the myopia and presbyopia treatment market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.
By Type
This section covers the regional outlook, which accentuates current and future demand for the Myopia and Presbyopia Treatment market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the myopia and presbyopia treatment market include Ziemer Ophthalmic Systems AG, NIDEK CO. LTD., Johnson & Johnson Vision, Essilor Ltd., Zeiss International, ALCON VISION LLC, Bausch & Lomb Incorporated., Carl Zeiss AG, Orasis Pharmaceuticals, Regeneron Pharmaceuticals Inc., Haag-Streit UK, Topcon Corporation, AbbVie, Sydnexis, The Cooper Companies Inc. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
1 . PREFACE
1.1. Report Description
1.1.1. Objective
1.1.2. Target Audience
1.1.3. Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
1.3.1. Market Research Process
1.3.2. Market Research Methodology
2 . EXECUTIVE SUMMARY
2.1. Highlights of Market
2.2. Global Market Snapshot
3 . MYOPIA AND PRESBYOPIA TREATMENT – INDUSTRY ANALYSIS
3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter’s Five Force Analysis
3.7. Market Attractiveness Analysis
3.7.1 Market Attractiveness Analysis By Corrective (Prescription Lenses, Contact Lenses, Intraocular Lenses)
3.7.2 Market Attractiveness Analysis By Region
4 . VALUE CHAIN ANALYSIS
4.1. Value Chain Analysis
4.2. Raw Material Analysis
4.2.1. List of Raw Materials
4.2.2. Raw Material Manufactures List
4.2.3. Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
4.4.1. Direct Marketing
4.4.2. Indirect Marketing
4.4.3. Marketing Channel Development Trend
5 . IMPACT ANALYSIS OF COVID-19 OUTBREAK
6 . GLOBAL MYOPIA AND PRESBYOPIA TREATMENT MARKET ANALYSIS BY TYPE
6.1 Overview by Type
6.2 Historical and Forecast Data
6.3 Analysis by Type
6.4 Corrective (Prescription Lenses, Contact Lenses, Intraocular Lenses) Historic and Forecast Sales by Regions
6.5 Surgical Historic and Forecast Sales by Regions
6.6 Drugs Historic and Forecast Sales by Regions
7 . GLOBAL MYOPIA AND PRESBYOPIA TREATMENT MARKET ANALYSIS BY GEOGRAPHY
7.1. Regional Outlook
7.2. Introduction
7.3. North America Sales Analysis
7.3.1. Overview, Historic and Forecast Sales Analysis
7.3.2. North America By Segment Sales Analysis
7.3.3. North America By Country Sales Analysis
7.3.4. United State Sales Analysis
7.3.5. Canada Sales Analysis
7.3.6. Mexico Sales Analysis
7.4. Europe Sales Analysis
7.4.1. Overview, Historic and Forecast Sales Analysis
7.4.2. Europe by Segment Sales Analysis
7.4.3. Europe by Country Sales Analysis
7.4.4. United Kingdom Sales Analysis
7.4.5. France Sales Analysis
7.4.6. Germany Sales Analysis
7.4.7. Italy Sales Analysis
7.4.8. Russia Sales Analysis
7.4.9. Rest Of Europe Sales Analysis
7.5. Asia Pacific Sales Analysis
7.5.1. Overview, Historic and Forecast Sales Analysis
7.5.2. Asia Pacific by Segment Sales Analysis
7.5.3. Asia Pacific by Country Sales Analysis
7.5.4. China Sales Analysis
7.5.5. India Sales Analysis
7.5.6. Japan Sales Analysis
7.5.7. South Korea Sales Analysis
7.5.8. Australia Sales Analysis
7.5.9. Rest Of Asia Pacific Sales Analysis
7.6. Latin America Sales Analysis
7.6.1. Overview, Historic and Forecast Sales Analysis
7.6.2. Latin America by Segment Sales Analysis
7.6.3. Latin America by Country Sales Analysis
7.6.4. Brazil Sales Analysis
7.6.5. Argentina Sales Analysis
7.6.6. Peru Sales Analysis
7.6.7. Chile Sales Analysis
7.6.8. Rest of Latin America Sales Analysis
7.7. Middle East & Africa Sales Analysis
7.7.1. Overview, Historic and Forecast Sales Analysis
7.7.2. Middle East & Africa by Segment Sales Analysis
7.7.3. Middle East & Africa by Country Sales Analysis
7.7.4. Saudi Arabia Sales Analysis
7.7.5. UAE Sales Analysis
7.7.6. Israel Sales Analysis
7.7.7. South Africa Sales Analysis
7.7.8. Rest Of Middle East And Africa Sales Analysis
8 . COMPETITIVE LANDSCAPE OF THE MYOPIA AND PRESBYOPIA TREATMENT COMPANIES
8.1. Myopia And Presbyopia Treatment Market Competition
8.2. Partnership/Collaboration/Agreement
8.3. Merger And Acquisitions
8.4. New Product Launch
8.5. Other Developments
9 . COMPANY PROFILES OF MYOPIA AND PRESBYOPIA TREATMENT INDUSTRY
9.1. Top Companies Market Share Analysis
9.2. Market Concentration Rate
9.3. Ziemer Ophthalmic Systems AG
9.3.1. Company Overview
9.3.2. Company Revenue
9.3.3. Products
9.3.4. Recent Developments
9.4. NIDEK CO. LTD.
9.4.1. Company Overview
9.4.2. Company Revenue
9.4.3. Products
9.4.4. Recent Developments
9.5. Johnson & Johnson Vision
9.5.1. Company Overview
9.5.2. Company Revenue
9.5.3. Products
9.5.4. Recent Developments
9.6. Essilor Ltd.
9.6.1. Company Overview
9.6.2. Company Revenue
9.6.3. Products
9.6.4. Recent Developments
9.7. Zeiss International
9.7.1. Company Overview
9.7.2. Company Revenue
9.7.3. Products
9.7.4. Recent Developments
9.8. ALCON VISION LLC
9.8.1. Company Overview
9.8.2. Company Revenue
9.8.3. Products
9.8.4. Recent Developments
9.9. Bausch & Lomb Incorporated.
9.9.1. Company Overview
9.9.2. Company Revenue
9.9.3. Products
9.9.4. Recent Developments
9.10. Carl Zeiss AG
9.10.1. Company Overview
9.10.2. Company Revenue
9.10.3. Products
9.10.4. Recent Developments
9.11. Orasis Pharmaceuticals
9.11.1. Company Overview
9.11.2. Company Revenue
9.11.3. Products
9.11.4. Recent Developments
9.12. Regeneron Pharmaceuticals Inc.
9.12.1. Company Overview
9.12.2. Company Revenue
9.12.3. Products
9.12.4. Recent Developments
9.13. Haag-Streit UK
9.13.1. Company Overview
9.13.2. Company Revenue
9.13.3. Products
9.13.4. Recent Developments
9.14. Topcon Corporation
9.14.1. Company Overview
9.14.2. Company Revenue
9.14.3. Products
9.14.4. Recent Developments
9.15. AbbVie
9.15.1. Company Overview
9.15.2. Company Revenue
9.15.3. Products
9.15.4. Recent Developments
9.16. Sydnexis
9.16.1. Company Overview
9.16.2. Company Revenue
9.16.3. Products
9.16.4. Recent Developments
9.17. The Cooper Companies Inc.
9.17.1. Company Overview
9.17.2. Company Revenue
9.17.3. Products
9.17.4. Recent Developments
*Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies
LIST OF TABLES
LIST OF FIGURES
* Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.
Avail customized purchase options to meet your exact research needs: